Loading…
Option Care Health, Inc. is projected to rise to $23.53 by 2027, a +9% move from its current price of $21.64. OPCH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $21.12 | $21.65 | $22.20 | +0.05% |
| May 30 | $20.91 | $21.66 | $22.44 | +0.10% |
| May 31 | $20.76 | $21.67 | $22.63 | +0.15% |
| Jun 1 | $20.63 | $21.68 | $22.79 | +0.20% |
| Jun 2 | $20.52 | $21.69 | $22.93 | +0.25% |
| Jun 3 | $20.42 | $21.70 | $23.07 | +0.30% |
| Jun 4 | $20.33 | $21.71 | $23.19 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.33 | $21.71 | $23.19 | +0.35% |
| Week 2 | $19.85 | $21.79 | $23.91 | +0.69% |
| Week 3 | $19.51 | $21.87 | $24.50 | +1.04% |
| Week 4 | $19.24 | $21.94 | $25.03 | +1.39% |
| Week 5 | $19.00 | $22.02 | $25.51 | +1.74% |
| Week 6 | $18.80 | $22.09 | $25.96 | +2.09% |
| Week 7 | $18.63 | $22.17 | $26.38 | +2.45% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Option Care Health, Inc. is a healthcare company that provides home and alternate site infusion services in the United States. The company offers anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Option Care Health, Inc. (OPCH) operates in the Healthcare sector. It currently trades with a price of $20.93 per share and a market capitalization of $3.29B, placing it at rank 1648 by market cap. The stock is tracked under the symbol OPCH.
A major floor 35.2% below — a decisive break under it would weaken the trend.
The nearest floor, 9.8% below — buyers have tended to step in here.
The nearest ceiling, 33.2% above — a clean break opens room to run.
A major ceiling 69.1% above — clearing it would confirm fresh momentum.
Key OPCH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPCH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.53 | Buy | $21.30 | Buy |
| MA 10 | $20.75 | Buy | $21.16 | Buy |
| MA 20 | $20.91 | Buy | $21.91 | Sell |
| MA 50 | $25.33 | Sell | $24.74 | Sell |
| MA 100 | $29.36 | Sell | $27.16 | Sell |
| MA 200 | $29.16 | Sell | $28.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.79 | Neutral |
| Stoch RSI (14) | 94.42 | Sell |
| CCI (20) | 50.08 | Neutral |
| Williams %R (14) | -21.77 | Info |
| MACD (12,26,9) | 0.42 | Buy |
| ROC (12) | 5.51 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 78.23 | Neutral |
| TRIX (15) | -1.06 | Sell |
| Awesome (5,34) | -2.49 | Sell |
| Ultimate (7,14,28) | 62.80 | Neutral |
| Momentum (10) | 2.05 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 21.68 | Sell |
| ADX (14) | 32.47 | Sell |
| ATR (14) | 0.62 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 40, indicating neither overbought nor oversold conditions. The stock trades below its near-term and longer-term moving averages, with SMA50 at $25.64 and SMA200 at $29.23. The 30-day price range spans $17.64 to $24.84, offering near-term support at $19.52 and resistance at $28.93.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.52 | $21.64 | $29.56 | 0% | Neutral | |
| $18.82 | $23.53 | $31.06 | +9% | Neutral | |
| $19.15 | $24.53 | $33.47 | +13% | Neutral | |
| $20.59 | $26.93 | $37.71 | +24% | Bullish | |
| $23.74 | $31.60 | $45.24 | +46% | Bullish | |
| $26.42 | $35.76 | $52.20 | +65% | Bullish | |
| $26.13 | $35.91 | $53.34 | +66% | Bullish | |
| $27.10 | $37.78 | $57.02 | +75% | Bullish | |
| $28.22 | $39.88 | $61.08 | +84% | Bullish | |
| $27.58 | $39.50 | $61.33 | +83% | Bullish | |
| $37.24 | $56.58 | $93.03 | +161% | Bullish | |
| $69.97 | $117.59 | $210.32 | +443% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.52 | $21.64 | $25.42 | +0.00% |
| June 2026 | $19.03 | $22.30 | $26.73 | +3.05% |
| July 2026 | $19.17 | $22.64 | $27.47 | +1.51% |
| August 2026 | $18.95 | $22.51 | $27.58 | -0.54% |
| September 2026 | $19.34 | $23.09 | $28.50 | +2.55% |
| October 2026 | $19.96 | $23.94 | $29.75 | +3.68% |
| November 2026 | $19.79 | $23.83 | $29.80 | -0.45% |
| December 2026 | $19.44 | $23.50 | $29.56 | -1.39% |
Click any year to see its month-by-month OPCH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect OPCH to range from $19.52 to $29.56 through 2026. The $21.64 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The OPCH price prediction for 2027 points to an average of $23.53 (low $18.82, high $31.06) — a potential gain of +9% on today's $21.64. Price action looks broadly range-bound.
In 2028, OPCH is projected to trade between $19.15 and $33.47, averaging $24.53 — a potential gain of +13% from today's $21.64. That is up +4% on the projected 2027 average. A consolidation phase looks the most probable path here.
Option Care Health, Inc.'s 2029 outlook centres on $26.93, within a $20.59 to $37.71 range. That is up +10% on the projected 2028 average. That marks a +24% change versus current levels. Momentum favours further upside here.
By 2030, OPCH could reach as high as $45.24, with a base case around $31.60 and support toward $23.74 — roughly +46% from $21.64. Buyers look set to stay in control over this stretch.
Expect OPCH to range from $26.42 to $52.20 through 2031. The $35.76 average target implies a +65% move from current prices. That is up +13% on the projected 2030 average. Momentum favours further upside here.
The OPCH price prediction for 2032 points to an average of $35.91 (low $26.13, high $53.34) — a potential gain of +66% on today's $21.64. Buyers look set to stay in control over this stretch.
In 2033, OPCH is projected to trade between $27.10 and $57.02, averaging $37.78 — a potential gain of +75% from today's $21.64. That is up +5% on the projected 2032 average. Momentum favours further upside here.
Option Care Health, Inc.'s 2034 outlook centres on $39.88, within a $28.22 to $61.08 range. That is up +6% on the projected 2033 average. That marks a +84% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, OPCH could reach as high as $61.33, with a base case around $39.50 and support toward $27.58 — roughly +83% from $21.64. Momentum favours further upside here.
Expect OPCH to range from $37.24 to $93.03 through 2040. The $56.58 average target implies a +161% move from current prices. That is up +43% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The OPCH price prediction for 2050 points to an average of $117.59 (low $69.97, high $210.32) — a potential gain of +443% on today's $21.64. Momentum favours further upside here.
Investing $1,000 in OPCH today (≈ 46.210721 OPCH) could be worth
$5,434.1
+$4,434.1 (+443%) by 2050 · US Dollar
Based on the average projected OPCH price of $117.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPCHwould be worth at today's price.
$1,000 invested in OPCH on May 27, 2025 (≈ 31.133251 OPCH) would be worth
$673.72
-$326.28 (-32.6%) today · 0.67× · US Dollar
Based on a OPCH entry price of $32.12 vs. today's $21.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.23 | $973.46 | -2.7% |
| 1 month ago | $27.93 | $774.79 | -22.5% |
| 3 months ago | $31.89 | $678.58 | -32.1% |
| 6 months ago | $31.1 | $695.82 | -30.4% |
| 1 year ago | $32.12 | $673.72 | -32.6% |
| All time (5.0y) ago | $18.56 | $1,165.95 | +16.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPCH forecast.
Our base-case forecast reaches $43.00 around 2040.
Implied market cap at $43.00: $6.75B
The multi-year forecast shows a bullish trajectory after 2028, with 2029 min $19.83, avg $26.10, max $36.83 (ROI 24.7) and sentiment BULLISH, followed by 2030 min $22.88, avg $30.69, max $44.32 (ROI 46.6) and sentiment BULLISH. The years 2031–2035 continue the bullish pattern, with 2031 avg $34.46 (ROI 64.7), 2032 avg $34.87 (ROI 66.6), 2033 avg $36.60 (ROI 74.9), 2034 avg $38.25 (ROI 82.8), and 2035 avg $38.10 (ROI 82.1). Longer horizon forecasts show stronger upside: 2040 avg $54.34 (ROI 159.7) and 2050 avg $113.99 (ROI 444.6), both with bullish sentiment.
The forecasted max values rise accordingly (e.g., 2031 max $50.78, 2032 max $52.31, 2033 max $55.82, 2034 max $59.22, 2035 max $59.83, 2040 max $90.52, 2050 max $207.05). These figures illustrate a potential substantial upside over the coming years, but they are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
2030 forecast: avg $30.69 with min $22.88 and max $44.32; ROI 46.6; sentiment BULLISH.
Forecast shows neutral for 2026–2028 and bullish from 2029 onward, with rising averages and ROI: 2029 avg $26.10 (ROI 24.7), 2030 avg $30.69 (ROI 46.6), and 2050 avg $113.99 (ROI 444.6); sentiment turns BULLISH in later years.
Yes. 2031 max $50.78; 2032 max $52.31; 2033 max $55.82; 2034 max $59.22; 2035 max $59.83; 2040 max $90.52; 2050 max $207.05.
Current price is $20.93. 30-day range: $17.64 to $24.84.
Near-term support is $19.52 and resistance is $28.93.
Option Care Health, Inc. Community Discussion
0Share your Option Care Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.